Regulation of Intestinal Inflammation by Walnut-Derived Bioactive Compounds
Nutrients · 2024
DOI: 10.3390/nu16162643 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, 2024. Verfasst von Kexin Dai und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Case Western Reserve University School of Medicine, Cleveland, OH 44106-4909, USA. Hauptthemen laut MEDLINE: Juglans, Anti-Inflammatory Agents, Inflammatory Bowel Diseases, Nuts. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 121 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS.
Abstract (Originalsprache)
Walnuts (Juglans regia L.) have shown promising effects in terms of ameliorating inflammatory bowel disease (IBD), attributed to their abundant bioactive compounds. This review comprehensively illustrates the key mechanisms underlying the therapeutic potential of walnuts in IBD management, including the modulation of intestinal mucosa permeability, the regulation of inflammatory pathways (such as NF-kB, COX/COX2, MAPCK/MAPK, and iNOS/NOS), relieving oxidative stress, and the modulation of gut microbiota. Furthermore, we highlight walnut-derived anti-inflammatory compounds, such as polyunsaturated fatty acids (PUFA; e.g., ω-3 PUFA), tocopherols, phytosterols, sphingolipids, phospholipids, phenolic compounds, flavonoids, and tannins. We also discuss unique anti-inflammatory compounds such as peptides and polysaccharides, including their extraction and preparation methods. Our review provides a theoretical foundation for dietary walnut supplementation in IBD management and provides guidance for academia and industry. In future, research should focus on the targeted isolation and purification of walnut-derived anti-inflammatory compounds or optimizing extraction methods to enhance their yields, thereby helping the food industry to develop dietary supplements or walnut-derived functional foods tailored for IBD patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, Case Western Reserve University School of Medicine, Cleveland, OH 44106-4909, USA.
- Department of Nutrition, Case Western Reserve University School of Medicine, Cleveland, OH 44106-4909, USA.
- Department of Biochemistry, Case Western Reserve University School of Medicine, Cleveland, OH 44106-4909, USA.
- Germfree Mouse Models Core, Case Western Reserve University School of Medicine, Cleveland, OH 44106-4909, USA.
- University Hospitals Research and Education Institute, University Hospitals Cleveland Medical Center, Cleveland, OH 44106-4909, USA.
- Department of Molecular Biology and Microbiology, Case Western Reserve University School of Medicine, Cleveland, OH 44106-4909, USA.
ORCID-Profile: Kexin Dai, Neel Agarwal, Alexander Rodriguez-Palacios, Abigail Raffner Basson
Förderung
- NIDDK NIH HHS
Zitieren
APA
Dai, K., Agarwal, N., Rodriguez-Palacios, A., & Basson, A. R. (2024). Regulation of Intestinal Inflammation by Walnut-Derived Bioactive Compounds. Nutrients. https://doi.org/10.3390/nu16162643
Vancouver
Dai K, Agarwal N, Rodriguez-Palacios A, Basson AR. Regulation of Intestinal Inflammation by Walnut-Derived Bioactive Compounds. Nutrients. 2024. doi:10.3390/nu16162643
BibTeX
@article{Dai2024,
author = {Dai, Kexin and Agarwal, Neel and Rodriguez-Palacios, Alexander and Basson, Abigail Raffner},
title = {Regulation of Intestinal Inflammation by Walnut-Derived Bioactive Compounds},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16162643}
}
EUVIMED